Iluvien not approved in japan?

Is Iluvien (fluocinolone acetonide intravitreal implant) approved in Japan?

Iluvien (fluocinolone acetonide intravitreal implant) is not approved in Japan based on the provided information.

Why might Iluvien not be approved in Japan?

When an ophthalmic drug or implant is not approved in a specific country, the reasons typically include one or more of the following: the manufacturer has not filed for approval in that market, regulators have not accepted the submitted data for safety/efficacy, or additional requirements (such as manufacturing, labeling, or local clinical evidence) are not met.

What are patients and doctors using in Japan instead?

In markets where Iluvien is not available, treatment often shifts to other approved options for chronic diabetic macular edema, commonly including anti-VEGF injections and other steroid options where available.

Could Iluvien gain approval later in Japan?

Yes. Lack of approval now does not rule out future authorization. If the company submits a dossier (or supplements it with additional clinical, safety, or manufacturing data) and regulators complete their review, approval could come later.

What to check if you’re trying to confirm availability?

For Japan-specific availability and approval status, the most reliable sources are Japan’s official drug listings and the brand’s prescribing information for that region (if published).

Sources

No sources were provided with your question, so I can’t cite a specific Japan regulator or listing here.